BioVie Inc. Announces Pricing of Public Offering
CARSON CITY, Nev., Sept. 23, 2024 ( GLOBE NEWSWIRE ) -- BioVie Inc. ( NASDAQ: BIVI ) , ( "BioVie" or the "Company" ) , a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders, ...
| Ticker |
Sentiment |
Impact |
|
BIVI
|
Somewhat Bullish
|
30 %
|
|
STT
|
Neutral
|
4 %
|
